Systemic Lupus Erythematosus as a Risk Factor for Cervical Cancer and its Precursor Conditions: Assessment Using Pap Smear and Histopathology

Crossmark: check for updates

Authors

  • Mai A. Gobran Department of Pathology, Zagazig University, Ash Sharqiyah Governorate, Egypt
  • Soheir El-Ghoneimey Department of Dermatology and Venereology, Zagazig University, Ash Sharqiyah Governorate, Egypt
  • Safaa A. S. Ibrahim Department of Obstetrics and Gynecology, Zagazig University, Ash Sharqiyah Governorate, Egypt
  • Sabah Mohamedhanafy Department of Pathology, Zagazig University, Ash Sharqiyah Governorate, Egypt

DOI:

https://doi.org/10.17140/GOROJ-8-155

Keywords:

Systemic lupus erythematosus (SLE), Cancer, Cervix, Low grade squamous intra-epithelial lesions, High grade squamous-intra epithelial lesions, Cervical, Intraepithelial neoplasia, Squamous cell carcinoma

Abstract

Background
Cancer of the cervix is a common cause of malignancy. Its association with systemic lupus erythematosus (SLE) is debatable.
Objective
Early detection of cervical pre-neoplastic lesion in SLE patients.
Method
A case control study was performed on 64 SLE group and 64 control group using a colposcopy, pap smear and histopathological examination.
Conclusion
This study revealed that preneoplastic and neoplastic lesions of the cervix were higher in the SLE group.

References

Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervi-cal cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med. 2008; 5(6): e132. doi: 10.1371/journal. pmed.0050132

Howley PM, Lowy DR. Papillomaviruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. IL, USA: Wolters Kluwer; 2012: 2197-2229.

Ault A. Epidemiology and natural history of human papilloma-virus infections in the female genital tract. J Infect Dis Obstet Gynecol. 2006; 2006 Suppl: 40470. doi: 10.1155/IDOG/2006/40470

Ishida WS, Singto Y, Kanjanavirojkul N, Chatchawan U, Yue-nyao P, Settheetham D, et al. Co-risk factors for HPV infection in northeastern Thai women with cervical carcinoma. Asian Pac J Cancer Prev. 2004; 5: 383-386.

Jones MH, Jerkins D, Singer A. Regular audit of colposcopic biopsies in women with a mildly dyskaryotic or borderline cervical smear results in fewer cases of CIN III. Cytopathology. 2006; 7(1): 17-24. doi: 10.1046/j.1365-2303.1996.37582375.x 6 Gobran MA, et al

Kjaer SK, Chackerian B, van den Brule AJC, Svare EI, Paull G, Walbomers JM, Schiller JT, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2010; 10: 101-106.

Al-Sherbeni H, Fahmy A, Sherif N. Predisposition to cervical atypia in SLE: A clinical and cytopathological study. Autoimmune Dis. 2015; 2015: 751853. doi: 10.1155/2015/751853

ACOG Practice Bulletin. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol. 2013; 102(2): 417-427. doi: 10.1016/s0029-7844(03)00745-2

Harris RWC, Brinton LA, Cowdell RH, Skegg DC, Smith PG, Vessey MP, et al. Characteristics of women with dfysplasia or car-cinoma in situ of the cervix uteri. Br J Cancer. 1980; 42: 359-369. doi: 10.1038/bjc.1980.246

Baron RM, Kenny DA. The moderator-mediator variable dis-tinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Coc Psychol. 1986; 51(6): 1173-1182. doi: 10.1037//0022-3514.51.6.1173

Dean OF. statistical methods in scientific research. Eur J Sci Res. 2006; 14(3).

Cantor SB, Atkinson EN, Cardenas-Turanzas M, Benedet JL, Follen M, MacAulay C. Natural history of cervical intraepitheli-al neoplasia: A meta-analysis. Acta Cytol. 2005; 49: 405-415. doi: 10.1159/000326174

Ben-Menachem E. Review article: Systemic lupus erythemato-sus: A review for anesthesiologists. Anesth Analg. 2010; 111: 665- 676. doi: 10.1213/ANE.0b013e3181e8138e

Dobkin PL, Da Costa D, Fortin PR, Edworthy S, Barr S, Esdai-le JM, et al. Living with lupus: A prospective pan-Canadian study. J Rheumatol. 2001; 28: 2442-2448.

Esmaeili H, Ghahremanzadeh K. Association of pap smear ab-normalities with autoimmune disorder. Pak J Biol Sci. 2011; 14(10): 600-604. doi: 10.3923/pjbs.2011.600.604

Cao L, Tong H, Xu G, Liu P, Meng H, Wang J, et al. Systemic lupus erythematous and malignancy risk: A meta-analysis. PLoS One. 2015; 10(4): e0122964. doi: 10.1371/journal.pone.0122964

Bao YP, Li N, Smith JS, Y-L Qiao, ACCPAB members. Human papillomavirus type distribution in women from Asia: A meta-analysis. Int J Gynecol Cancer. 2008; 18: 71-79. doi: 10.1111/j.1525- 1438.2007.00959.x

Bernatsky S, Clarke A, Labreque J, Boivin J-F, Costenbader KH, Urowitz MB, et al. Lymphoma risk in systemic lupus: Effects of disease activity versus treatment. Arthritis Rheum Dis. 2014; 73(1): Original Research | Volume 8 | Number 1| 138-142. doi: 10.1136/annrheumdis-2012-202099

Liu H, Ding Q, Yang K, Zhang T, Li G, Wu G. Meta-analysis of SLE and the risk of cervical neoplasia. Rheumatology. 2011; 50(2): 343-348. doi: 10.1093/rheumatology/keq304

Lee Y-H, Choe J-Y, Park S-H, Park Y-W, Lee S-S, Kang Y-M, et al. Prevalence of human papilloma virus infections and cervical cy-tological abnormalities among Korean women with SLE. J Korean Med Sci. 2010; 25: 1431-1437. doi: 10.3346/jkms.2010.25.10.1431

Wadström H, Elizabeth V, Sjöwall C, Askling J, Simard JF. Cervical neoplasia in systemic lupus erythematosus: A nationwide study. Rheumatology (Oxford). 2017; 56(4): 613-619. doi: 10.1093/ rheumatology/kew459

Nath R, Mant C, Luxton J, Hughes G, Raju KS, Shepherd P, et al. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in sys-temic lupus erythematosus patients. Arthritis Rheum. 2007; 57: 619- 625. doi: 10.1002/art.22667

Dresang LT. Cervical cancer with a normal Pap. WMJ. 2003; 102(5): 4. Submit your article to this journal | https://openventio.org/submit-manuscript/ Original Research | Volume 8 | Number 1| Gobran MA, et al

Bernatsky S, Joseph L, Boivin J-F, Gordon C, Urowitz M, Glad-man D, et al. The relationship between cancer and medication ex-posures in systemic lupus erythaematosus: A case–cohort study. Ann Rheum Dis. 2008; 67: 74-79. doi: 10.1136/ard.2006.069039

Kale M, Ramsey-Goldman R, Gordon C, Clarke AE, Bernatsky S. Malignancies in SLE. Autoimmun Rev. 2010; 9(4): doi: 10.1016/j. autrev.2009.07.004

Dey D, Kenu E, Isenberg DA. Cancer complicating SLE – a dichotomy emerging from a nested case-control study. Lupus. 2013; 22(9): 919-927. doi: 10.1177/0961203313497118

Dhar JP, Kmak D, Bhan R, Pishorodi L, Ager J, Sokol RJ. Ab-normal cervicovaginal cytology in women with lupus: A retro-spective cohort study. Gynecol Oncol. 2001; 82: 4-6. doi: 10.1006/ gyno.2001.6207

Girbash EF, Atta DS, Fahmy DS, Abdelwahab SM, Therwat I. Abnormal Pap tests in systemic lupus erythematosis: A cytopatho-logical and human papillomavirus testing study. Int J Adv Res. 2016; 4(5): 1707-1715. doi: 10.21474/IJAR01/355

Downloads

Published

2022-08-03

How to Cite

Mai A. Gobran, Soheir El-Ghoneimey, Safaa A. S. Ibrahim, & Sabah Mohamedhanafy. (2022). Systemic Lupus Erythematosus as a Risk Factor for Cervical Cancer and its Precursor Conditions: Assessment Using Pap Smear and Histopathology. Gynecology and Obstetrics Research, 8(1), 1–7. https://doi.org/10.17140/GOROJ-8-155

Issue

Vol. 8 No. 1 (2022): Volume 8 Issue 1 2022

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.